scholarly journals Contemporary trend of reduced-dose non-vitamin K anticoagulants in Japanese patients with atrial fibrillation: A cross-sectional analysis of a multicenter outpatient registry

2019 ◽  
Vol 73 (1) ◽  
pp. 14-21 ◽  
Author(s):  
Tomohiko Ono ◽  
Nobuhiro Ikemura ◽  
Takehiro Kimura ◽  
Ikuko Ueda ◽  
Hiroaki Tanaka ◽  
...  
2021 ◽  
Vol 39 ◽  
pp. 101060
Author(s):  
Sarah N. Forrester ◽  
David D. McManus ◽  
Jane S. Saczynski ◽  
Isabelle C. Pierre-Louis ◽  
Benita A. Bamgbade ◽  
...  

Nutrients ◽  
2019 ◽  
Vol 11 (4) ◽  
pp. 787 ◽  
Author(s):  
Francesco Bolzetta ◽  
Nicola Veronese ◽  
Brendon Stubbs ◽  
Marianna Noale ◽  
Alberto Vaona ◽  
...  

Few studies assessed the associations between dietary vitamin K and depressive symptoms. We aimed to investigate the association between dietary vitamin K and depressive symptoms in a large cohort of North American People. In this cross-sectional analysis, 4,375 participants that were aged 45–79 years from the Osteoarthritis Initiative were included. Dietary vitamin K intake was collected through a semi-quantitative food frequency questionnaire and categorized in quartiles. Depressive symptoms were diagnosed using the 20-item Center for Epidemiologic Studies-Depression (CES-D) ≥ 16. To investigate the associations between vitamin K intake and depressive symptoms, logistic regression analysis were run, which adjusted for potential confounders. Overall, 437 (=10%) subjects had depressive symptoms. After adjusting for 11 confounders, people with the highest dietary vitamin K intake had lower odds of having depressive symptoms (OR = 0.58; 95%CI: 0.43–0.80). This effect was only present in people not taking vitamin D supplementation. In conclusion, higher dietary vitamin K intake was significantly associated with a lower presence of depressive symptoms, also after accounting for potential confounders. Future longitudinal research is required to explore the directionality of the association.


2014 ◽  
Vol 12 (3) ◽  
pp. 258-263 ◽  
Author(s):  
Juergen Ringwald ◽  
Marina Lehmann ◽  
Nicole Niemeyer ◽  
Isabell Seifert ◽  
Anne Daubmann ◽  
...  

2019 ◽  
Vol 277 ◽  
pp. 125-129 ◽  
Author(s):  
Yidan Guo ◽  
Jingli Gao ◽  
Pengpeng Ye ◽  
Aijun Xing ◽  
Yuntao Wu ◽  
...  

2017 ◽  
Vol 67 (662) ◽  
pp. e588-e597 ◽  
Author(s):  
Nicola Adderley ◽  
Ronan Ryan ◽  
Tom Marshall

BackgroundUnderuse of anticoagulants in atrial fibrillation (AF) is an international problem, which has often been attributed to the presence of contraindications to treatment. No studies have assessed the influence of contraindications on anticoagulant prescribing in the UK.AimTo determine the influence of contraindications on anticoagulant prescribing in patients with AF in the UK.Design and settingCross-sectional analysis of primary care data from 645 general practices contributing to The Health Improvement Network, a large UK database of electronic primary care records.MethodTwelve sequential cross-sectional analyses were carried out from 2004 to 2015. Patients with a diagnosis of AF aged ≥35 years and registered for at least 1 year were included. Outcome measure was prescription of anticoagulant medication.ResultsOver the 12 study years, the proportion of eligible patients with AF with contraindications who were prescribed anticoagulants increased from 40.1% (95% confidence interval [CI] = 38.3 to 41.9) to 67.2% (95% CI = 65.6 to 68.8), and the proportion of those without contraindications prescribed anticoagulants increased from 42.1% (95% CI = 41.6 to 42.6) to 67.7% (95% CI = 67.2 to 68.1). In patients with a recent history of major bleeding or aneurysm, prescribing rates increased from 44.3% (95% CI = 42.2 to 46.5) and 34.8% (95% CI = 29.4 to 40.6) in 2004 to 71.7% (95% CI = 69.9 to 73.5) and 63.2% (95% CI = 58.3 to 67.8) in 2015, respectively, comparable with rates in patients without contraindications.ConclusionThe presence or absence of recorded contraindications has little influence on the decision to prescribe anticoagulants for the prevention of stroke in patients with AF. The study analysis suggests that, nationally, 38 000 patients with AF with contraindications are treated with anticoagulants. This has implications for patient safety.


PLoS ONE ◽  
2013 ◽  
Vol 8 (5) ◽  
pp. e61979 ◽  
Author(s):  
Mohammed A. Mohammed ◽  
Tom Marshall ◽  
Krishnarajah Nirantharakumar ◽  
Andrew Stevens ◽  
David Fitzmaurice

Sign in / Sign up

Export Citation Format

Share Document